213 related articles for article (PubMed ID: 23150684)
1. NGAL controls the metastatic potential of anaplastic thyroid carcinoma cells.
Volpe V; Raia Z; Sanguigno L; Somma D; Mastrovito P; Moscato F; Mellone S; Leonardi A; Pacifico F
J Clin Endocrinol Metab; 2013 Jan; 98(1):228-35. PubMed ID: 23150684
[TBL] [Abstract][Full Text] [Related]
2. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells.
Iannetti A; Pacifico F; Acquaviva R; Lavorgna A; Crescenzi E; Vascotto C; Tell G; Salzano AM; Scaloni A; Vuttariello E; Chiappetta G; Formisano S; Leonardi A
Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14058-63. PubMed ID: 18768801
[TBL] [Abstract][Full Text] [Related]
3. Lipocalin2 enhances the matrix metalloproteinase-9 activity and invasion of extravillous trophoblasts under hypoxia.
Kobara H; Miyamoto T; Suzuki A; Asaka R; Yamada Y; Ishikawa K; Kikuchi N; Ohira S; Shiozawa T
Placenta; 2013 Nov; 34(11):1036-43. PubMed ID: 23972287
[TBL] [Abstract][Full Text] [Related]
4. [Effect of Inhibiting NGAL Gene Expression on A549 Lung Cancer Cell Migration and Invasion].
Tang J; Li J; Li S; Li J; Yu C; Wei C
Zhongguo Fei Ai Za Zhi; 2015 Apr; 18(4):187-92. PubMed ID: 25936881
[TBL] [Abstract][Full Text] [Related]
5. NGAL knockdown by siRNA in human cholangiocarcinoma cells suppressed invasion by reducing NGAL/MMP-9 complex formation.
Nuntagowat C; Leelawat K; Tohtong R
Clin Exp Metastasis; 2010 May; 27(5):295-305. PubMed ID: 20373132
[TBL] [Abstract][Full Text] [Related]
6. Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells.
Lee HJ; Lee EK; Lee KJ; Hong SW; Yoon Y; Kim JS
Int J Cancer; 2006 May; 118(10):2490-7. PubMed ID: 16381001
[TBL] [Abstract][Full Text] [Related]
7. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients.
Fernández CA; Yan L; Louis G; Yang J; Kutok JL; Moses MA
Clin Cancer Res; 2005 Aug; 11(15):5390-5. PubMed ID: 16061852
[TBL] [Abstract][Full Text] [Related]
8. C/EBP ζ targets to neutrophil gelatinase-associated lipocalin (NGAL) as a repressor for metastasis of MDA-MB-231 cells.
Wang L; Li H; Wang J; Gao W; Lin Y; Jin W; Chang G; Wang R; Li Q; Ma L; Pang T
Biochim Biophys Acta; 2011 Oct; 1813(10):1803-13. PubMed ID: 21741997
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells.
Tong Z; Chakraborty S; Sung B; Koolwal P; Kaur S; Aggarwal BB; Mani SA; Bresalier RS; Batra SK; Guha S
Cancer; 2011 Jun; 117(11):2408-18. PubMed ID: 24048788
[TBL] [Abstract][Full Text] [Related]
10. Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-alpha is controlled by IkappaB-zeta but neither by C/EBP-beta nor C/EBP-delta.
Karlsen JR; Borregaard N; Cowland JB
J Biol Chem; 2010 May; 285(19):14088-100. PubMed ID: 20220144
[TBL] [Abstract][Full Text] [Related]
11. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction.
Hemdahl AL; Gabrielsen A; Zhu C; Eriksson P; Hedin U; Kastrup J; Thorén P; Hansson GK
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):136-42. PubMed ID: 16254208
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?
Diamanti-Kandarakis E; Livadas S; Kandarakis SA; Margeli A; Papassotiriou I
Eur J Endocrinol; 2008 Apr; 158(4):525-31. PubMed ID: 18362300
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of neutrophil gelatinase-associated lipocalin in oral squamous cell carcinoma: relation to cell differentiation.
Hiromoto T; Noguchi K; Yamamura M; Zushi Y; Segawa E; Takaoka K; Moridera K; Kishimoto H; Urade M
Oncol Rep; 2011 Dec; 26(6):1415-21. PubMed ID: 21874256
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9.
Gupta K; Shukla M; Cowland JB; Malemud CJ; Haqqi TM
Arthritis Rheum; 2007 Oct; 56(10):3326-35. PubMed ID: 17907186
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.
Provatopoulou X; Gounaris A; Kalogera E; Zagouri F; Flessas I; Goussetis E; Nonni A; Papassotiriou I; Zografos G
BMC Cancer; 2009 Nov; 9():390. PubMed ID: 19889214
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene.
Bolignano D; Donato V; Lacquaniti A; Fazio MR; Bono C; Coppolino G; Buemi M
Cancer Lett; 2010 Feb; 288(1):10-6. PubMed ID: 19540040
[TBL] [Abstract][Full Text] [Related]
17. [Functions of neutrophil gelatinase-associated lipocalin in the esophageal carcinoma cell line SHEEC].
Li EM; Xu LY; Cai WJ; Xiong HQ; Shen ZY; Zeng Y
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):247-54. PubMed ID: 12621549
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of Neutrophil gelatinase-associated lipocalin(NGAL) expression in primary rectal cancer.
Zhang XF; Zhang Y; Zhang XH; Zhou SM; Yang GG; Wang OC; Guo GL; Yang GY; Hu XQ
BMC Cancer; 2009 May; 9():134. PubMed ID: 19419554
[TBL] [Abstract][Full Text] [Related]
19. Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease.
Tsai HT; Su PH; Lee TH; Tee YT; Lin LY; Yang SF; Wang PH
Clin Chim Acta; 2011 Jun; 412(13-14):1252-6. PubMed ID: 21439274
[TBL] [Abstract][Full Text] [Related]
20. NGAL Mediates Anaplastic Thyroid Carcinoma Cells Survival Through FAS/CD95 Inhibition.
Crescenzi E; Mellone S; Gragnano G; Iaccarino A; Leonardi A; Pacifico F
Endocrinology; 2023 Dec; 165(2):. PubMed ID: 38091978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
